Skip to content

Anxiety: all studies

Page 259 of 773: studies 2,581 to 2,590 of 7,721, newest first. Back to the anxiety overview

Research

LOS BENEFICIOS DEL YOGA Y DE LA MEDITACIÓN PARA EL APRENDIZAJE DE UN INSTRUMENTO MUSICAL

New Trends in Qualitative Research July 7, 2020 Nerea Olabe, Cristina Pereira 1 citation

The article presents an action research work developed with the cello class of a conservatory with the intention of studying the benefits of yoga and meditation in the learning of an instrument and in the management of some problems inherent to music students, such as musculoskeletal disorders and stage anxiety. The results are intended to help improve teaching practice, distancing musical...

Who Turns to Amazonian Medicine for Treatment of Substance Use Disorder? Patient Characteristics at the Takiwasi Addiction Treatment Center

Journal of Studies on Alcohol and Drugs July 1, 2020 Ilana Berlowitz, Heinrich Walt, Christian Ghasarian et al. 19 citations

Our results suggest that the Amazonian medicine-based therapy attracts a diverse patient group not limited to regional residents and may be particularly appealing to more impaired SUD patients with a history of unsuccessful treatment. The sample's cultural diversity suggests an existing interest in such therapies among international SUD treatment-seeking patients. These findings are relevant in...

Using Mind-Body Modalities via Telemedicine during the COVID-19 Crisis: Cases in the Republic of Korea.

International Journal of Environmental Research and Public Health June 22, 2020 Chan-Young Kwon, Hui-Yong Kwak, Jong Woo Kim

The coronavirus disease 2019 (COVID-19) pandemic affected the world, and its deleterious effects on human domestic life, society, economics, and especially on human mental health are expected to continue. Mental health experts highlighted health issues this pandemic may cause, such as depression, anxiety, obsessive compulsive disorder, and post-traumatic stress disorder. Mind-body intervention,...

DOI: 10.3390/ijerph17124477 (opens in new tab) Full text (opens in new tab) Anxiety Humans Pneumonia, viral Coronavirus infections +10

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Journal of Psychoactive Drugs June 12, 2020 Jason B. Luoma, Christina Chwyl, Geoff J. Bathje et al. 206 citations

After a two-decade hiatus in which research on psychedelics was essentially halted, placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions have begun to be published. We identified nine randomized, placebo-controlled clinical trials of psychedelic-assisted therapy published since 1994. Studies examined psilocybin, LSD (lysergic acid diethylamide),...

Psychedelic-assisted psychotherapy for depression: How dire is the need? How could we do it?

Journal of Psychedelic Studies June 1, 2020 Mitch Earleywine, Joseph A. de Leo 12 citations

Abstract Despite the popular support for psychedelics as aids for depression, academics and the public frequently overestimate the efficacy of available medications and psychotherapies. Metaanalyses reveal that antidepressant medications alone help only one in four patients and rarely surpass credible placebos. Their effects, though statistically significant, might not impress depressed...

Prevalence and Clinical Picture of Sleep Paralysis in a Polish Student Sample.

International Journal of Environmental Research and Public Health May 18, 2020 Paulina Wróbel-knybel, Hanna Karakuła-juchnowicz, Michał Flis et al.

Sleep paralysis (SP) is a psychobiological phenomenon caused by temporary desynchrony in the architecture of rapid eye movement (REM) sleep. It affects approximately 7.6% of the general population during their lifetime. The aim of this study was to assess (1) the prevalence of SP among Polish students in Lublin (n = 439) using self-reported online surveys, (2) the frequency of SP-related...

Dynamic coupling of whole-brain neuronal and neurotransmitter systems

Proceedings of the National Academy of Sciences April 13, 2020 Morten L. Kringelbach, Josephine Cruzat, Joana Cabral et al. 326 citations

Significance In a technical tour de force, we have created a framework demonstrating the underlying fundamental principles of bidirectional coupling of neuronal and neurotransmitter dynamical systems. Specifically, in the present study, we combined multimodal neuroimaging data to causally explain the functional effects of specific serotoninergic receptor (5-HT 2A R) stimulation with psilocybin...

Brain Network Organization During Mindful Acceptance of Emotions

bioRxiv (Cold Spring Harbor Laboratory) April 1, 2020 Matthew L. Dixon, Manesh Girn, Kalina Christoff 14 citations preprint

Abstract Individuals use various strategies to cope with challenging emotions such as anxiety. Mindful acceptance involves broadening attentional scope and fully experiencing present moment sensory feelings (whether pleasant or unpleasant) without judgment or elaboration. In contrast, narrative-evaluation involves focusing on a narrow band of sensory experience and generating an elaborate...

Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives

Journal of Palliative Medicine April 1, 2020 Yvan Beaussant, Justin J. Sanders, Zachary Sager et al. 39 citations

Background: Recent and preprohibition studies show that patients with serious illness might benefit from psychedelic-assisted therapies for a range of symptoms, physical, psychosocial, and existential. Objective: To explore the potential roles and research priorities of these therapies in patients with serious illness. Design, Setting, and Participants: Qualitative study based on semistructured...

DOI: 10.1089/jpm.2019.0603 (opens in new tab) Anxiety Psychosocial Thematic analysis Distress +4

Psychedelic Psychiatry's Brave New World.

Cell April 1, 2020 David Nutt, David Erritzøe, Robin Carhart-Harris 330 citations

After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and...